10172017Headline:

Lansing, Michigan

HomeMichiganLansing

Email David Mittleman David Mittleman on LinkedIn David Mittleman on Facebook David Mittleman on Avvo
David Mittleman
David Mittleman
Attorney • (888) 227-4770

Qualitest Pharmaceuticals Recalls 250 Million Insulin Syringes

Comments Off

Qualitest Pharmaceuticals is recalling 250 million Accusure insulin syringes because the needle can detach from the syringe. If the needle does detach, it can become stuck in the insulin vial, get pushed back into the syringe, or get stuck in the skin after an injection.

Thus far, the company has received four complaints related to the needle detaching from the syringe. However, no injuries have been reported as a result of the problem.

The recall includes all syringes, regardless of lot number, that were sold between January 2002 and October 2009 to wholesale and retail pharmacies nationwide and in Puerto Rico. The company has requested that consumers stop using the syringes if they were purchased during the indicated time period and to contact the company with concerns. Furthermore, consumers can report problems associated with the syringes to the Food and Drug Administration.